180 related articles for article (PubMed ID: 32592462)
1. DeepAntigen: a novel method for neoantigen prioritization via 3D genome and deep sparse learning.
Shi Y; Guo Z; Su X; Meng L; Zhang M; Sun J; Wu C; Zheng M; Shang X; Zou X; Cheng W; Yu Y; Cai Y; Zhang C; Cai W; Da LT; He G; Han ZG
Bioinformatics; 2020 Dec; 36(19):4894-4901. PubMed ID: 32592462
[TBL] [Abstract][Full Text] [Related]
2. A novel neoantigen discovery approach based on chromatin high order conformation.
Shi Y; Zhang M; Meng L; Su X; Shang X; Guo Z; Li Q; Lin M; Zou X; Luo Q; Yu Y; Wu Y; Da L; Cai TW; He G; Han ZG
BMC Med Genomics; 2020 Aug; 13(Suppl 6):62. PubMed ID: 32854726
[TBL] [Abstract][Full Text] [Related]
3. GNIFdb: a neoantigen intrinsic feature database for glioma.
Li W; Sun T; Li M; He Y; Li L; Wang L; Wang H; Li J; Wen H; Liu Y; Chen Y; Fan Y; Xin B; Zhang J
Database (Oxford); 2022 Feb; 2022():. PubMed ID: 35150127
[TBL] [Abstract][Full Text] [Related]
4. Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.
Bai P; Li Y; Zhou Q; Xia J; Wei PC; Deng H; Wu M; Chan SK; Kappler JW; Zhou Y; Tran E; Marrack P; Yin L
Oncoimmunology; 2021 Jan; 10(1):1868130. PubMed ID: 33537173
[TBL] [Abstract][Full Text] [Related]
5. Machine learning methods and harmonized datasets improve immunogenic neoantigen prediction.
Müller M; Huber F; Arnaud M; Kraemer AI; Altimiras ER; Michaux J; Taillandier-Coindard M; Chiffelle J; Murgues B; Gehret T; Auger A; Stevenson BJ; Coukos G; Harari A; Bassani-Sternberg M
Immunity; 2023 Nov; 56(11):2650-2663.e6. PubMed ID: 37816353
[TBL] [Abstract][Full Text] [Related]
6. DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity.
Wu J; Wang W; Zhang J; Zhou B; Zhao W; Su Z; Gu X; Wu J; Zhou Z; Chen S
Front Immunol; 2019; 10():2559. PubMed ID: 31736974
[TBL] [Abstract][Full Text] [Related]
7. Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information.
Kim S; Kim HS; Kim E; Lee MG; Shin EC; Paik S; Kim S
Ann Oncol; 2018 Apr; 29(4):1030-1036. PubMed ID: 29360924
[TBL] [Abstract][Full Text] [Related]
8. Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy.
Shah RK; Cygan E; Kozlik T; Colina A; Zamora AE
Front Immunol; 2023; 14():1301100. PubMed ID: 38149253
[TBL] [Abstract][Full Text] [Related]
9. TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification.
Tang Y; Wang Y; Wang J; Li M; Peng L; Wei G; Zhang Y; Li J; Gao Z
BMC Bioinformatics; 2020 Nov; 21(1):532. PubMed ID: 33208106
[TBL] [Abstract][Full Text] [Related]
10. NeoScore Integrates Characteristics of the Neoantigen:MHC Class I Interaction and Expression to Accurately Prioritize Immunogenic Neoantigens.
Borden ES; Ghafoor S; Buetow KH; LaFleur BJ; Wilson MA; Hastings KT
J Immunol; 2022 Apr; 208(7):1813-1827. PubMed ID: 35304420
[TBL] [Abstract][Full Text] [Related]
11. Neodb: a comprehensive neoantigen database and discovery platform for cancer immunotherapy.
Wu T; Chen J; Diao K; Wang G; Wang J; Yao H; Liu XS
Database (Oxford); 2023 Jun; 2023():. PubMed ID: 37311149
[TBL] [Abstract][Full Text] [Related]
12. Seq2Neo: A Comprehensive Pipeline for Cancer Neoantigen Immunogenicity Prediction.
Diao K; Chen J; Wu T; Wang X; Wang G; Sun X; Zhao X; Wu C; Wang J; Yao H; Gerarduzzi C; Liu XS
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232923
[TBL] [Abstract][Full Text] [Related]
13. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors.
Shi Y; Jing B; Xi R
Genome Biol; 2023 Jul; 24(1):169. PubMed ID: 37461029
[TBL] [Abstract][Full Text] [Related]
15. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
[TBL] [Abstract][Full Text] [Related]
16. Identification of neoantigens for individualized therapeutic cancer vaccines.
Lang F; Schrörs B; Löwer M; Türeci Ö; Sahin U
Nat Rev Drug Discov; 2022 Apr; 21(4):261-282. PubMed ID: 35105974
[TBL] [Abstract][Full Text] [Related]
17. ImmuneMirror: A machine learning-based integrative pipeline and web server for neoantigen prediction.
Chuwdhury GS; Guo Y; Chiang CL; Lam KO; Kam NW; Liu Z; Dai W
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38343325
[TBL] [Abstract][Full Text] [Related]
18. Computational prediction of MHC anchor locations guides neoantigen identification and prioritization.
Xia H; McMichael J; Becker-Hapak M; Onyeador OC; Buchli R; McClain E; Pence P; Supabphol S; Richters MM; Basu A; Ramirez CA; Puig-Saus C; Cotto KC; Freshour SL; Hundal J; Kiwala S; Goedegebuure SP; Johanns TM; Dunn GP; Ribas A; Miller CA; Gillanders WE; Fehniger TA; Griffith OL; Griffith M
Sci Immunol; 2023 Apr; 8(82):eabg2200. PubMed ID: 37027480
[TBL] [Abstract][Full Text] [Related]
19. Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation.
Borden ES; Buetow KH; Wilson MA; Hastings KT
Front Oncol; 2022; 12():836821. PubMed ID: 35311072
[TBL] [Abstract][Full Text] [Related]
20. Improvement in neoantigen prediction via integration of RNA sequencing data for variant calling.
Nguyen BQT; Tran TPD; Nguyen HT; Nguyen TN; Pham TMQ; Nguyen HTP; Tran DH; Nguyen V; Tran TS; Pham TN; Le MT; Phan MD; Giang H; Nguyen HN; Tran LS
Front Immunol; 2023; 14():1251603. PubMed ID: 37731488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
